Podcast Episodes
Back to Search
Where’s the Beef? Inside the Fragile Cattle Market
Inflation in the US has cooled from pandemic peaks, but there’s a grocery product telling a different story: beef. The price of uncooked ground beef …
1 week, 4 days ago
The Sixth Bureau, Episode 2: The Spy’s Diary
In Episode 2 of The Sixth Bureau, a limited-run series from The Big Take, we learn how China’s Ministry of State Security recruits experts in the Wes…
2 weeks, 2 days ago
The Sixth Bureau, Episode 1: Your Friend From Nanjing
It’s an open secret that the Chinese government has engaged in a global campaign to acquire intellectual property from foreign rivals. At the center …
2 weeks, 2 days ago
Trump Accounts Promise Free Money. What's the Catch?
In July, American parents will be eligible to open Trump Accounts on behalf of their children. The administration touts these investment accounts as …
2 weeks, 2 days ago
Finally, Some Good News on US Jobs
The latest jobs report from the US Bureau of Labor Statistics is a mixed bag. January’s numbers came in much stronger than expected — but revisions o…
2 weeks, 3 days ago
What Takaichi’s Landslide Election Win Means for Japan
Japanese Prime Minister Sanae Takaichi secured a historic election win, positioning her as the nation’s strongest leader in the postwar era.
On today…
2 weeks, 4 days ago
Can the US and Iran Make a Deal?
The prospect of US military action in Iran and the possibility of regional war continue to loom over indirect talks between the two countries.
Israel…
2 weeks, 5 days ago
Weekend Listen: George Saunders Imagines an Oil Exec’s Deathbed
What is the best way to tell a climate story? This week on Zero, Akshat Rathi speaks with Booker Prize-winning novelist George Saunders. His new nove…
3 weeks ago
Pro Betters Flock to Prediction Markets
On today’s Big Take podcast, professional sports gambler Rufus Peabody discusses why he has shifted more of his betting to prediction markets like Ka…
3 weeks, 1 day ago
Generic Versions of Weight Loss Drugs Will Upend the Market
Shares of Novo Nordisk were down Thursday morning after Hims & Hers introduced a compounded version of its Wegovy pill. The dip came two days after N…
3 weeks, 2 days ago